As resistin has been suggested as a marker of the severity of myocardium ischemic injury [43], the change of resistin by CoQ10 in dyslipidemic patients indicated a further decreased risk for them to develop atherosclerosis. This evidence concerns the gene RETN and atherosclerosis.